News Sentiment

CLPT sentiment intelligence

Clearpoint Neuro Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 73 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 17.50 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 62

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-6.5% over one week, +30.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -6.5% Price reacting lower
Trend fit Trend active 30.2% over four weeks
Fair value 58.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 51
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 62
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 11
TradingView 7
Moomoo 4
Seeking Alpha 2
Stock Traders Daily 2
Investing.com Nigeria 2
Investing.com Canada 2

Event Lens

What the news is about

Classified themes
Market update 43
Earnings 24
Analyst action 2
Deals and strategy 2
Macro sensitivity 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 73
TradingKey Direct company coverage

Clearpoint Neuro Inc (CLPT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Clearpoint Neuro Inc (CLPT) by TradingKey. It details the company's current valuation score of 9.41, ranking it 16th in the Healthcare Equipment & Supplies industry, and its P/E ratio. The analysis also highlights that relevant data f

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 07:10
Source
TradingKey
The Globe and Mail Direct company coverage

Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE)

Analysts are showing bullish sentiment towards two healthcare stocks, ClearPoint Neuro (CLPT) and uniQure (QURE). Stifel Nicolaus maintained a Buy rating on ClearPoint Neuro with a $25.00 price target, while the consensus price target is $27.50, suggesting a significant upside. F

Tone
Positive 92/100
Event
Analyst action
Published
23 Jun 2026 02:11
Source
The Globe and Mail
Stock Titan Direct company coverage

ClearPoint Neuro (CLPT) CEO sells 61,843 shares after exercising options

ClearPoint Neuro (CLPT) CEO and President Joseph Burnett executed an exercise-and-sell transaction, exercising 60,000 stock options at $2.50 per share and selling 60,000 directly held shares at an average of $17.79. Additionally, a trust managed by Burnett sold 1,843 shares at $1

Tone
Negative 40/100
Event
Market update
Published
22 Jun 2026 20:11
Source
Stock Titan